MedPath
HSA Approval

POLI-CIFLOXIN 250 TABLET 250 mg

SIN10308P

POLI-CIFLOXIN 250 TABLET 250 mg

POLI-CIFLOXIN 250 TABLET 250 mg

October 23, 1998

MD PHARMACEUTICALS PTE. LTD.

MD PHARMACEUTICALS PTE. LTD.

Regulatory Information

MD PHARMACEUTICALS PTE. LTD.

MD PHARMACEUTICALS PTE. LTD.

Therapeutic

Prescription Only

Formulation Information

TABLET, FILM COATED

Dosage: The usual dose is 250–500 mg twice daily or as prescribed by a physician. A single dose of 250 mg for the treatment of gonorrhoea.

ORAL

Medical Information

Indications: For treatment of infections caused by sensitive to Ciprofloxacin gram positive and gram negative pathogens in respiratory tract, ear, sinuses, kidneys, urinary tract and etc.

Contraindications: Hypersensitivity to ciprofloxacin or other quinolones. Children, adolescents, pregnancy and lactation.

J01MA02

ciprofloxacin

Manufacturer Information

MD PHARMACEUTICALS PTE. LTD.

POLIPHARM CO LTD

Active Ingredients

CIPROFLOXACIN HCl MONOHYDRATE EQV CIPROFLOXACIN

250 mg

Ciprofloxacin

Documents

Package Inserts

Poli-Cifloxin 250mg PI.pdf

Approved: February 3, 2021

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

POLI-CIFLOXIN 250 TABLET 250 mg - HSA Approval | MedPath